ArticleBiotechnology letters2025
Enhancement of reduction of biodesulfurization end products by Paenibacillus strains.
Article in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A functional and applied perspective of Vitreoscilla hemoglobin: from oxygen carriage to biotechnological innovation.Biotechnology letters · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The work reported here aimed to enhance the reduction of the downstream intermediates 2-hydroxybiphenyl (2-HBP) and 2-(2'hydroxyphenyl ethan-1-al) produced by biodesulfurization of DBT (dibenzothiophene) and BT (benzothiophene) using Paenibacillus strains (32O-W and 32O-Y). Salicylaldehyde was used as a surrogate for 2-(2'hydroxybiphenyl ethan-1-al), as the two compounds are structurally very similar while the latter is not commercially available. Five strategies were tested using growth in media containing either 2-HBP or salicylaldehyde: use of single strain cultures, co-culturing, genetic engineering to express Vitreoscilla hemoglobin (VHb), cell immobilization, and nanoparticle coating of cells. Cell growth and reduction of 2-HBP and salicylaldehyde were measured during 96 h of culturing. Regarding 2-HBP reduction, 32O-Y was generally better than 32O-W (about 50% for free cells, and as much as 16% for immobilized cells, and 24% for coated cells); co-culturing did not provide any consistent advantage, while VHb expression increased utilization only for 32O-W (by about 50%). Immobilization and coating resulted in large improvements for both strains (as much as 3700%). Free, immobilized, and coated cells of 32O-Y all removed salicylaldehyde, while only immobilized 32O-W cells were able to do so. For 32O-Y, co-culturing and coating, but not VHb expression, resulted in improvements in salicylaldehyde reduction (of up to 31%). Thus, alginate immobilization or nanoparticle coating of bacterial cells may be useful approaches for enhancing the reduction of DBT or BT biodesulfurization end products, and thus the overall biodesulfurization process for petroleum and petroleum products.
Indexed as
Identifiers
39907823What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.